tiprankstipranks
Protagenic Therapeutics (PTIX)
OTHER OTC:PTIX
US Market
PTIX
Protagenic Therapeutics
RESEARCH TOOLSreports
Want to see PTIX full AI Analyst Report?

Protagenic Therapeutics (PTIX) Income Statement

95 Followers

Protagenic Therapeutics Income Statement

Last quarter (Q4 2025), Protagenic Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Protagenic Therapeutics's net income was $2.21M. See Protagenic Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Mar 24Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -37.72K$ -50.29K$ -28.22K$ -30.00$ 0.00
Operating Expenses
$ 5.81M$ 5.70M$ 4.50M$ 3.56M$ 4.14M
Depreciation and Amortization
$ 37.72K$ 50.29K$ 28.22K$ 30.00$ 286.00
EBITDA
$ -8.02M$ -5.47M$ -4.50M$ -3.42M$ -4.14M
Operating Income
$ -5.83M$ -5.70M$ -4.53M$ -3.56M$ -4.14M
Other Income/Expenses
$ 675.23K$ 175.61K$ -474.00K$ 2.28K$ -383.00K
Pretax Income
$ -5.16M$ -5.53M$ -5.00M$ -3.56M$ -4.52M
Net Income
$ -5.16M$ -5.53M$ -5.00M$ -3.56M$ -4.52M
Per Share Metrics
Basic EPS
$ -3.45$ -1.13$ -1.15$ -0.82$ -1.24
Diluted EPS
$ -3.45$ -1.13$ -1.15$ -0.82$ -1.24
Weighted Average Shares Outstanding
 1.93M 4.90M 4.34M 4.32M 3.69M
Weighted Average Shares Outstanding (Diluted)
 1.93M 4.90M 4.34M 4.32M 3.69M
Currency in USD

Protagenic Therapeutics Earnings and Revenue History